Antibiotic demonstrates non-inferiority to a leading gonorrhoea treatment
European Pharmaceutical Review
APRIL 18, 2024
percent success rates in patients with uncomplicated urogenital gonorrhoea (GC). EAGLE-1 (non-inferiority urogenital gonorrhoea trial) compared the efficacy and safety of gepotidacin to ceftriaxone plus azithromycin in uncomplicated urogenital gonorrhoea.
Let's personalize your content